Structural aspects of ligand binding to and electron transfer in bacterial and fungal p450s

被引:66
|
作者
Pylypenko, O [1 ]
Schlichting, I
机构
[1] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany
[2] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany
关键词
heme protein; cytochrome P450; crystal structure; ligand binding; induced-fit mechanism; hemoprotein;
D O I
10.1146/annurev.biochem.73.011303.073711
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 enzymes are heme-containing monooxygenases that are named after an absorption band at 450 nm when complexed with carbon monoxide. They catalyze a wide variety of reactions and are unique in their ability to hydroxylate nonactivated hydrocarbons. P450 enzymes are involved in numerous biological processes, which include the biosynthesis of lipids, steroids, antibiotics, and the degradation of xenobiotics. In line with the variety of reactions catalyzed, the size of their substrates varies significantly. Some P450s have open active sites (e.g., BM3), and some have shielded active sites that open only transiently (e.g., P450cam), whereas others bind the substrate only when attached to carrier proteins (e.g., Oxy proteins). Structural aspects of both organic and gaseous ligand binding and electron transfer are described.
引用
收藏
页码:991 / 1018
页数:28
相关论文
共 50 条
  • [41] P450s and UGTs: Key Players in the Structural Diversity of Triterpenoid Saponins
    Seki, Hikaru
    Tamura, Keita
    Muranaka, Toshiya
    PLANT AND CELL PHYSIOLOGY, 2015, 56 (08) : 1463 - 1471
  • [42] In Silico Analysis of P450s and Their Role in Secondary Metabolism in the Bacterial Class Gammaproteobacteria
    Msomi, Ntombizethu Nokuphiwa
    Padayachee, Tiara
    Nzuza, Nomfundo
    Syed, Puleng Rosinah
    Krys, Justyna Dorota
    Chen, Wanping
    Gront, Dominik
    Nelson, David R.
    Syed, Khajamohiddin
    MOLECULES, 2021, 26 (06):
  • [43] Metabolism of antidepressant and neuroleptic drugs by cytochrome p450s: Clinical and interethnic aspects
    Bertilsson, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (05) : 606 - 609
  • [44] Screening of bacterial cytochrome P450s responsible for regiospecific hydroxylation of (iso)flavonoids
    Pandey, Bishnu Prasad
    Lee, Nahum
    Choi, Kwon-Young
    Jung, Eunok
    Jeong, Da-hye
    Kim, Byung-Gee
    ENZYME AND MICROBIAL TECHNOLOGY, 2011, 48 (4-5) : 386 - 392
  • [45] Fungal cytochrome P450s catalyzing hydroxylation of substituted toluenes to form their hydroxymethyl derivatives
    Teramoto, H
    Tanaka, H
    Wariishi, H
    FEMS MICROBIOLOGY LETTERS, 2004, 234 (02) : 255 - 260
  • [46] Cytochrome P450s as biomarkers for individualised drug therapy: genetic and epigenetic aspects
    Ingelman-Sundberg, M.
    FEBS JOURNAL, 2009, 276 : 25 - 25
  • [47] BIOACTIVATION OF LUMIRACOXIB BY P450S AND PEROXIDASES
    Kang, Ping
    Dalvie, Deepak K.
    Smith, Evan B.
    Renner, Matt
    DRUG METABOLISM REVIEWS, 2008, 40 : 121 - 122
  • [48] New functional twists for P450s
    Fasan, Rudi
    NATURE CHEMISTRY, 2017, 9 (07) : 609 - 611
  • [49] High-level heterologous expression of fungal cytochrome P450s in Escherichia coli
    Ichinose, Hirofumi
    Wariishi, Hiroyuki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 438 (02) : 289 - 294
  • [50] Regio-specific hydroxylation of isoflavonoids using bacterial cytochrome P450s
    Kim, Byung-Gee
    Choi, Kwon-Young
    Lee, Nahum
    Pandey, Bishnu Prasad
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2009, 108 : S98 - S99